Assessment of leptin and resistin levels in non-obese multiple myeloma patients and their relation with Ig level and disease stage
Introduction: Multiple myeloma (MM) accounts for approximately 0.8% of all cancer diagnoses and 0.9% of cancer deaths. Leptin receptors were expressed on CD34+ cells. Resistin receptors were expressed on inflammatory cells and pro-inflammatory cytokines increase the expression of resistin on monocyt...
Main Authors: | Noha E. Esheba, Abeer Shahba, Ola El Shora |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2014-06-01
|
Series: | Journal of the Egyptian National Cancer Institute |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S111003621400020X |
Similar Items
-
Adiponectin, Leptin and Resistin in Patients with Psoriasis
by: Sylwia Słuczanowska-Głabowska, et al.
Published: (2023-01-01) -
Obesity, Serum Resistin and Leptin Levels Linked to Coronary Artery Disease
by: Farzaneh Montazerifar, et al. -
Estimation of Beta Two Microglobulins, Fetuin-A, Resistin Serum Level in Iraqi Multiple Myeloma Patients
by: Ali S. Salman, et al.
Published: (2020-12-01) -
Effects of 8 Weeks of Combined Rehabilitation Training on Plasma Levels of Leptin, Adiponectin, and Resistin in Middle-Aged Men after CABG
by: Hossein Nikkar, et al.
Published: (2023-01-01) -
Circulating leptin and resistin levels in a Romanian rheumatoid arthritis population
by: Cristian Vasile Petra, et al.
Published: (2020-06-01)